SCHEMBL24740422

SCHEMBL24740422

COc1ncc2[nH]c(C(=O)NC(C)C)cc2c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.48
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RCE1 Q9Y256 1/20 0.41
ALPL P05186 2/20 0.39
KDM5A P29375 1/20 0.39
MAPK1 P28482 6/20 0.39
APOBEC3G Q9HC16 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
ROCK2 O75116 4/20 0.37
ROCK1 Q13464 1/20 0.37
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
HASPIN Q8TF76 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24112885 0.87 ALOX15 (0.44) ALOX15KMT2AKDM4EALDH1A1MAPT
SCHEMBL24019831 0.84 ALOX15 (0.47) ALOX15KDM5AKDM4EALDH1A1MAPT
SCHEMBL24740112 0.77 MEN1 (0.48) ALOX15MEN1KMT2ARCE1KDM5A
SCHEMBL25758817 0.77 KMT2A (0.54) ALOX15MEN1KMT2ARCE1KDM4E
SCHEMBL24740842 0.76 ALOX15 (0.52) ALOX15MEN1KMT2ARCE1ALPL
SCHEMBL24019698 0.75 ALOX15 (0.37) ALOX15KDM5AMAPK1
SCHEMBL24740396 0.75 ALOX15 (0.57) ALOX15MEN1KMT2ARCE1ALPL
SCHEMBL25758892 0.74 ALOX15 (0.59) ALOX15ALPLADORA3ADORA2AADORA2B
SCHEMBL24739966 0.73 ALOX15 (0.58) ALOX15MEN1KMT2ARCE1MAPK1
SCHEMBL25758891 0.73 ALOX15 (0.54) ALOX15MEN1KMT2ARCE1ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2022-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL ALOX15 1749/4885MEN1 4164/4885KMT2A 3130/4885
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV ALOX15 1455/4885MEN1 4306/4885KMT2A 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.